Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ABCG2 -- a transporter for all seasons.

Balázs Sarkadi1, Csilla Ozvegy-Laczka, Katalin Német

  • 1National Medical Center, Institute of Haematology and Immunology, Membrane Research Group of the Hungarian Academy of Sciences, Diószegi u. 64, H-1113 Budapest, Hungary. sarkadi@biomembrane.hu

FEBS Letters
|May 29, 2004
PubMed
Summary

The human ABCG2 transporter protein protects cells from toxins and plays roles in stem cells and drug resistance. Genetic variations in ABCG2 can impact drug efficacy and toxicity in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Female metabolic resilience and male-biased protein quality defects under hypoxia in human brain organoids.

iScience·2026
Same author

Structural and functional analysis of OATP and ABCB1-mediated transport of pentamidine analogs: An integrated in vitro and in silico approach.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Quantitative analysis of DNA-GATA1 binding alterations linked to hematopoietic disorders.

The FEBS journal·2026
Same author

Genetic Modulation of Pluripotent Stem Cells.

Frontiers in bioscience (Landmark edition)·2026
Same author

Characterization of Novel Sigma Receptor Ligands Derived from Multicomponent Reactions as Efficacious Treatments for Neuropathic Pain.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Development and validation of combined in vitro and in vivo assays for evaluating the efficacy of strontium-chelating compounds.

Scientific reports·2025

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • The human ABCG2 protein is an ABC half-transporter involved in cellular defense.
  • It actively transports diverse compounds out of cells, protecting tissues like the intestine, liver, placenta, and blood-brain barrier.
  • ABCG2 is implicated in stem cell regulation and hypoxic responses.

Purpose of the Study:

  • To elucidate the multifaceted roles of the ABCG2 transporter.
  • To understand the clinical implications of ABCG2 in drug response and disease.

Main Methods:

  • The study focuses on the functional characteristics and biological significance of the ABCG2 transporter.
  • Analysis of genetic variations (polymorphisms) and their impact on drug disposition.
  • Investigation of ABCG2's role in multidrug resistance and stem cell applications.

Related Experiment Videos

Main Results:

  • ABCG2 actively effluxes a broad range of xenobiotics, contributing to cellular protection.
  • Single nucleotide polymorphisms in ABCG2 can significantly alter drug absorption and distribution, affecting treatment outcomes.
  • Overexpression of ABCG2 in cancer cells leads to multidrug resistance, while specific mutants are useful in gene therapy.

Conclusions:

  • ABCG2 is a critical determinant of xenobiotic transport, with significant physiological and clinical relevance.
  • Understanding ABCG2's function and genetic variability is essential for personalized medicine and cancer therapy.
  • ABCG2 holds potential for therapeutic applications, including stem cell-based gene therapies.